Batavia Prosperindo Internasional Tbk vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Batavia Prosperindo Internasional Tbk trades at Rp442 (market cap 4.37T, 1.1K 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp248 (market cap 167.37B, 23.2K 24h volume). The key difference: Batavia Prosperindo Internasional Tbk is far larger — about 26.1× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (23.2K versus 1.1K). Which is the better fit depends on your goals.
| BPII | OBAT | |
|---|---|---|
Market Cap | 4.37T | 167.37B |
Volume | 1.1K | 23.2K |
Lot | 11 | 232 |
Turnover | 486.2K | 5.73M |
Average Price | 442 | 246.93 |
Value | 486.2K | 5.73M |
Indicative Equilibrium Price | — | 246 |
Indicative Equilibrium Volume | — | 2.4K |
Trailing returns across standard periods
Latest headlines on both assets
PT Batavia Prosperindo Internasional Tbk (the Company) was established based on Notarial Deed No. 78 dated November 12, 1998 of Irawan Soerodjo, S.H., notary in Jakarta.
Read more on BPII →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →